Thursday, July 30, 2020

Majority say they won’t take COVID-19 vaccine within 1st year; (Study) 6 different ‘types’ of COVID-19, and Other C-Virus Updates

Most people would like to see a coronavirus vaccine approved this year, but far fewer are willing to be the first in line, a new poll has revealed.
Recently, WebMD surveyed its readers to explore their sense of urgency and concern regarding a vaccine for COVID-19. Of the 1,000 respondents, less than half, 42%, said they would opt-in for treatment within the first 12 months of a vaccine’s release.
Alarmingly, nearly a third of participants, 28%, told the medical news and information website that they had no intention of getting any vaccine, ever.
“This serves as a wake-up call,” said Dr. John Whyte, chief medical officer of WebMD, in an article appearing on the website. “If immunization rates are low, then we’re not going to achieve the level of herd immunity needed to protect us from this virus.”
Whyte later told The Post in an e-mail statement that now is “too early” to make a call.
LINK: Scientists identify six different ‘types’ of 
COVID-19 in new study
“It’s too early to know whether you should, or should not, be hesitant about getting the vaccine,” he said. “All we have now are the early results from a couple of major studies on a few hundred people.”
Health experts have estimated that 70% of a population must be protected either with a vaccine or by having recovered from the virus to reach “herd immunity” status — meaning COVID-19 will no longer be a pandemic-level threat and the world’s economies can safely reopen.
Unfortunately, many may be forced to achieve immunity the hard way — by getting the virus — as only 26% have said they’d step up within the first 90 days.
Read the rest of the story HERE and follow links below to related stories and resources:

Scientists identify six different ‘types’ of COVID-19 in new study

USA TODAY: Coronavirus Updates

WSJ: Coronavirus Live Updates

YAHOO NEWS: Coronavirus Live Updates

NEW YORK POST: Coronavirus The Latest

If you like what you see, please "Like" us on Facebook either here or here. Please follow us on Twitter here.

No comments: